FDA Panel To Review Safety Of Contrast Agent
In the wake of a wave of product liability lawsuits over contrast agents, the U.S. Food and Drug Administration has appointed an independent panel of experts to review the safety of...To view the full article, register now.
Already a subscriber? Click here to view full article